Spero Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 37.6M |
| FY2023 | 53.0M |
| FY2024 | 54.0M |
| FY2025 | 59.0M |
| FY2026 | 57.9M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2022 | 37.6M |
| FY2023 | 53.0M |
| FY2024 | 54.0M |
| FY2025 | 59.0M |
| FY2026 | 57.9M |